These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18239393)

  • 21. Value of adiponectin as predictor of 5-year all-cause mortality in patients with symptomatic peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) study.
    Dieplinger B; Haltmayer M; Poelz W; Mueller T
    Clin Chim Acta; 2009 Oct; 408(1-2):87-91. PubMed ID: 19646980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study.
    Jacobs M; van Greevenbroek MM; van der Kallen CJ; Ferreira I; Blaak EE; Feskens EJ; Jansen EH; Schalkwijk CG; Stehouwer CD
    Eur J Clin Invest; 2009 Jun; 39(6):437-44. PubMed ID: 19397692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flow mediated vasodilation and circulating concentrations of high sensitive C-reactive protein, interleukin-6 and tumor necrosis factor-alpha in normal pregnancy--The Cardiovascular Risk in Young Finns Study.
    Saarelainen H; Valtonen P; Punnonen K; Laitinen T; Raitakari OT; Juonala M; Heiskanen N; Lyyra-Laitinen T; Viikari JS; Heinonen S
    Clin Physiol Funct Imaging; 2009 Sep; 29(5):347-52. PubMed ID: 19489963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exercise training normalizes vascular dysfunction and improves central adiposity in obese adolescents.
    Watts K; Beye P; Siafarikas A; Davis EA; Jones TW; O'Driscoll G; Green DJ
    J Am Coll Cardiol; 2004 May; 43(10):1823-7. PubMed ID: 15145107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study.
    Juonala M; Viikari JS; Kähönen M; Solakivi T; Helenius H; Jula A; Marniemi J; Taittonen L; Laitinen T; Nikkari T; Raitakari OT
    J Am Coll Cardiol; 2008 Jul; 52(4):293-9. PubMed ID: 18634985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of caloric restriction with and without exercise training on oxidative stress and endothelial function in obese subjects with type 2 diabetes.
    Wycherley TP; Brinkworth GD; Noakes M; Buckley JD; Clifton PM
    Diabetes Obes Metab; 2008 Nov; 10(11):1062-73. PubMed ID: 18435772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial.
    Olijhoek JK; Hajer GR; van der Graaf Y; Dallinga-Thie GM; Visseren FL
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):145-50. PubMed ID: 18670365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects.
    Davison K; Coates AM; Buckley JD; Howe PR
    Int J Obes (Lond); 2008 Aug; 32(8):1289-96. PubMed ID: 18504447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The predictive value of brachial-ankle pulse wave velocity in coronary atherosclerosis and peripheral artery diseases in urban Chinese patients.
    Xu Y; Wu Y; Li J; Ma W; Guo X; Luo Y; Hu D
    Hypertens Res; 2008 Jun; 31(6):1079-85. PubMed ID: 18716354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG.
    Nam JS; Park JS; Cho MH; Jee SH; Lee HS; Ahn CW; Lowe WL; Kim KR
    Diabetes Res Clin Pract; 2009 May; 84(2):145-51. PubMed ID: 19261346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association between the metabolic syndrome and peripheral, but not coronary, artery disease is partly mediated by endothelial dysfunction: the CODAM study.
    Jacobs M; van Greevenbroek MM; van der Kallen CJ; Ferreira I; Blaak EE; Feskens EJ; Jansen EH; Schalkwijk CG; Stehouwer CD
    Eur J Clin Invest; 2011 Feb; 41(2):167-75. PubMed ID: 21039444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sarpogrelate hydrochloride, a selective 5-HT2A antagonist, improves vascular function in patients with peripheral arterial disease.
    Miyazaki M; Higashi Y; Goto C; Chayama K; Yoshizumi M; Sanada H; Orihashi K; Sueda T
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):221-7. PubMed ID: 17438407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients.
    Gokce N; Vita JA; McDonnell M; Forse AR; Istfan N; Stoeckl M; Lipinska I; Keaney JF; Apovian CM
    Am J Cardiol; 2005 Jan; 95(2):266-8. PubMed ID: 15642566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin resistance, metabolic syndrome and endothelial dysfunction.
    Bigazzi R; Bianchi S
    J Nephrol; 2007; 20(1):10-4. PubMed ID: 17347967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum resistin is associated with impaired endothelial function and a higher rate of adverse cardiac events in patients with peripheral artery disease.
    Ramirez JL; Khetani SA; Zahner GJ; Spaulding KA; Schaller MS; Gasper WJ; Hills NK; Schafer AL; Grenon SM
    J Vasc Surg; 2019 Feb; 69(2):497-506. PubMed ID: 30292618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Steroid pulse therapy impaired endothelial function while increasing plasma high molecule adiponectin concentration in patients with IgA nephropathy.
    Uchida HA; Nakamura Y; Kaihara M; Norii H; Hanayama Y; Sugiyama H; Maeshima Y; Yamasaki Y; Makino H
    Nephrol Dial Transplant; 2006 Dec; 21(12):3475-80. PubMed ID: 16951422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epicardial fat tissue thickness correlates with endothelial dysfunction and other cardiovascular risk factors in patients with metabolic syndrome.
    Aydin H; Toprak A; Deyneli O; Yazici D; Tarçin O; Sancak S; Yavuz D; Akalin S
    Metab Syndr Relat Disord; 2010 Jun; 8(3):229-34. PubMed ID: 20156077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of coronary dysfunction in obesity and insulin resistance.
    Knudson JD; Dincer UD; Bratz IN; Sturek M; Dick GM; Tune JD
    Microcirculation; 2007; 14(4-5):317-38. PubMed ID: 17613805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Espironolactone improves flow-mediated vasodilatation in subjects with the metabolic syndrome.
    Lovisi JC; Ezequiel DA; Costa MB; Bicalho TC; Barros FC; Souza Gdo C; Paula RB
    J Bras Nefrol; 2011 Dec; 33(4):463-6. PubMed ID: 22189811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Noninvasive assessment of endothelial activity in patients with peripheral arterial disease and cardiovascular risk factors.
    Fronek A; DiTomasso DG; Allison M
    Endothelium; 2007; 14(4-5):199-205. PubMed ID: 17922336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.